We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


HIV drug found to reduce the risk of catching HIV by over 90% in high risk individuals

Researchers at Manchester Royal Infirmary delivered part of a UK study, which has shown that a daily tablet (Truvada, an anti-retroviral) can reduce the risk of HIV transmission by 90% for gay men, and other men who have sex with men (MSM) at high risk of infection.

The study, which was sponsored by the UK Medical Research Council (MRC) and supported by the National Institute for Health Research, was carried out at Manchester, Brighton, London, York, Birmingham and Sheffield.

View the MRC press release http://www.proud.mrc.ac.uk/PDF/PROUD%20Statement%20161014.pdf